Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Oliva, Stefania
[Clear All Filters]
2023
Ocio EM
,
Perrot A
,
Bories P
,
San-Miguel JF
,
Blau IW
,
Karlin L
,
Martínez-López J
,
Wang S-Y
,
Bringhen S
,
Marcatti M
, et al.
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation.
Leukemia. 2023.
PubMed
Google Scholar
Autore F
,
Bramanti S
,
Lessi F
,
Innocenti I
,
Galli E
,
Rocchi S
,
Ribolla R
,
Derudas D
,
Oliva S
,
Stefanoni P
, et al.
Which is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome?
. Haematologica. 2023.
PubMed
Google Scholar
2018
Holstein SA
,
J Ye C
,
Howard A
,
Bhutani M
,
Gormley N
,
Hahn T
,
Hillengass J
,
Krishnan A
,
C Landgren O
,
Munshi NC
, et al.
Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling.
Biol Blood Marrow Transplant. 2018.
PubMed
Google Scholar
2014
Bringhen S
,
Petrucci MTeresa
,
Larocca A
,
Conticello C
,
Rossi D
,
Magarotto V
,
Musto P
,
Boccadifuoco L
,
Offidani M
,
Omedé P
, et al.
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study.
Blood. 2014.
PubMed
Google Scholar